SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-13-003594
Filing Date
2013-06-26
Accepted
2013-06-26 17:24:02
Documents
2
Period of Report
2013-06-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-18573.html 4  
1 PRIMARY DOCUMENT marketforms-18573.xml 4 3280
2 POA DOCUMENT poa.htm EX-24 3937
  Complete submission text file 0001214659-13-003594.txt   8629
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Issuer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANTHERA PHARMACEUTICALS, INC. 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address
Thompson David E. (Reporting) CIK: 0001484500 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34637 | Film No.: 13935353